Serious Transport Accidents in Adults With Attention-Deficit/Hyperactivity Disorder and the Effect of Medication A Population-Based Study

被引:219
作者
Chang, Zheng [1 ]
Lichtenstein, Paul [1 ]
D'Onofrio, Brian M. [2 ]
Sjolander, Arvid [1 ]
Larsson, Henrik [1 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden
[2] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA
基金
瑞典研究理事会;
关键词
DEFICIT-HYPERACTIVITY DISORDER; DOUBLE-BLIND; LISDEXAMFETAMINE DIMESYLATE; YOUNG-ADULTS; ADHD; DRIVERS; RISK; SAFETY; DISCONTINUATION; IMPAIRMENTS;
D O I
10.1001/jamapsychiatry.2013.4174
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
IMPORTANCE Studies have shown that attention-deficit/hyperactivity disorder (ADHD) is associated with transport accidents, but the magnitude of the association remains unclear. Most important, it is also unclear whether ADHD medication reduces this risk. OBJECTIVES To estimate the association between ADHD and the risk of serious transport accidents and to explore the extent to which ADHD medication influences this risk among patients with ADHD. DESIGN, SETTING, AND PARTICIPANTS In total, 17 408 patients with a diagnosis of ADHD were observed from January 1, 2006, through December 31, 2009, for serious transport accidents documented in Swedish national registers. The association between ADHD and accidents was estimated with Cox proportional hazards regression. To study the effect of ADHD medication, we used stratified Cox regression to compare the risk of accidents during the medication period with the risk during the nonmedication period within the same patients. MAIN OUTCOMES AND MEASURES Serious transport accident, identified as an emergency hospital visit or death due to transport accident. RESULTS Compared with individuals without ADHD, male patients with ADHD (adjusted hazard ratio, 1.47; 95% CI, 1.32-1.63) and female patients with ADHD (1.45; 1.24-1.71) had an increased risk of serious transport accidents. In male patients with ADHD, medication was associated with a 58% risk reduction (hazard ratio, 0.42; 95% CI, 0.23-0.75), but there was no statistically significant association in female patients. Estimates of the population-attributable fractions suggested that 41% to 49% of the accidents in male patients with ADHD could have been avoided if they had been receiving treatment during the entire follow-up. CONCLUSIONS AND RELEVANCE Attention-deficit/hyperactivity disorder is associated with an increased risk of serious transport accidents, and this risk seems to be possibly reduced by ADHD medication, at least among male patients. This should lead to increased awareness among clinicians and patients of the association between serious transport accidents and ADHD medication.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 35 条
  • [1] Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Adler, Lenard A.
    Goodman, David W.
    Kollins, Scott H.
    Weisler, Richard H.
    Krishnan, Suma
    Zhang, Yuxin
    Biederman, Joseph
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (09) : 1364 - +
  • [2] Allison P.D., 2009, Fixed effect regression models
  • [3] Under Diagnosis of Adult ADHD: Cultural Influences and Societal Burden
    Asherson, Philip
    Akehurst, Ron
    Kooij, J. J. Sandra
    Huss, Michael
    Beusterien, Kathleen
    Sasane, Rahul
    Gholizadeh, Shadi
    Hodgkins, Paul
    [J]. JOURNAL OF ATTENTION DISORDERS, 2012, 16 (05) : 20S - 38S
  • [4] Long-acting medications for the hyperkinetic disorders -: A systematic review and European treatment guideline
    Banaschewski, Tobias
    Coghill, David
    Santosh, Paramala
    Zuddas, Alessandro
    Asherson, Philip
    Buitelaar, Jan
    Danckaerts, Marina
    Doepfner, Manfred
    Faraone, Stephen V.
    Rothenberger, Aribert
    Sergeant, Joseph
    Steinhausen, Hans-Christoph
    Sonuga-Barke, Edmund J. S.
    Taylor, Eric
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2006, 15 (08) : 476 - 495
  • [5] Driving impairments in teens and adults with attention-deficit/hyperactivity disorder
    Barkley, RA
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2004, 27 (02) : 233 - +
  • [6] Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning
    Barkley, RA
    Murphy, KR
    Dupaul, GJ
    Bush, T
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2002, 8 (05) : 655 - 672
  • [7] A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance
    Barkley, Russell A.
    Cox, Daniel
    [J]. JOURNAL OF SAFETY RESEARCH, 2007, 38 (01) : 113 - 128
  • [8] The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: A randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm
    Biederman, Joseph
    Fried, Ronna
    Hammerness, Paul
    Surman, Craig
    Mehler, Bruce
    Petty, Carter R.
    Faraone, Stephen V.
    Miller, Carolyn
    Bourgeois, Michelle
    Meller, Benjamin
    Godfrey, Kathryn M.
    Reimer, Bryan
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2012, 46 (04) : 484 - 491
  • [9] Castle Lon, 2007, J Atten Disord, V10, P335, DOI 10.1177/1087054707299597
  • [10] Attributable risk function in the proportional hazards model for censored time-to-event
    Chen, Ying Qing
    Hu, Chengcheng
    Wang, Yan
    [J]. BIOSTATISTICS, 2006, 7 (04) : 515 - 529